Washington, D.C. — In a significant shift in federal health guidance, U.S. Department of Health and Human Services Secretary Robert F. Kennedy Jr. announced on Tuesday, May 28, 2025, that the government would no longer recommend COVID-19 vaccinations for healthy children and pregnant individuals. The directive, conveyed by Secretary Kennedy through a video statement posted on the social media platform X, marks a departure from previous public health advisories regarding these specific populations.
The core of Secretary Kennedy’s announcement centered on the removal of COVID-19 vaccines for healthy children and pregnant people from the official immunization schedule recommended by the Centers for Disease Control and Prevention (CDC). This action directly impacts the standing of the vaccine within the framework of routine vaccinations promoted by the nation’s leading public health agency.
Implications for Vaccine Access and Cost
The immediate consequence of this decision is anticipated to be a significant disruption in vaccine access for the affected groups. Removing a vaccine from the CDC’s recommended immunization schedule typically has cascading effects, particularly concerning insurance coverage. Experts predict that insurance companies are highly likely to cease covering the cost of COVID-19 vaccinations for healthy children and pregnant individuals now that the federal recommendation has been withdrawn.
This potential change in coverage could place a substantial financial burden on families and individuals seeking these vaccinations, effectively limiting access to those who can afford to pay out-of-pocket. Public health advocates voiced concerns that this could create inequities in vaccine availability, depending on socioeconomic status and insurance plans.
Medical Community Response and Condemnation
The announcement drew swift and sharp criticism from leading medical organizations. The American College of Obstetricians and Gynecologists (ACOG) issued a strong condemnation of the move, asserting that it runs contrary to established scientific evidence.
ACOG leadership emphasized that the science continues to support the recommendation for COVID-19 vaccination during pregnancy, highlighting the known risks associated with COVID-19 infection in expectant mothers. The organization stated that contracting COVID-19 during pregnancy can lead to major disability for both the mother and the developing fetus, citing data on increased risks of severe illness, preterm birth, stillbirth, and other adverse outcomes. They reiterated their stance that vaccination remains a critical tool for protecting pregnant individuals and their babies.
Other medical associations are expected to weigh in as they assess the implications of the HHS Secretary’s directive and its alignment, or lack thereof, with their own clinical guidelines and patient care recommendations.
Contextual Factors and Future Uncertainty
Secretary Kennedy’s decision comes at a time when the CDC itself is operating under challenging circumstances. The news item notes that the CDC is currently without an executive director, potentially adding a layer of complexity to the agency’s response and its ability to navigate the policy shift mandated by the head of its parent department, HHS.
The long-term effects of removing these recommendations are yet to be fully understood. Beyond insurance coverage, the change could influence state-level vaccine policies, public perception of vaccine safety and necessity, and the overall trajectory of the COVID-19 pandemic response in the United States.
Public health officials and medical professionals are now grappling with how to communicate risks and benefits to healthy children and pregnant individuals regarding COVID-19 vaccination in the absence of a federal recommendation and potentially without insurance coverage. The decision sets the stage for a period of uncertainty regarding vaccine accessibility and public health strategy for these specific demographic groups across the nation.
